2022 Market condition:
- Second year walking into COVID, with the government continue failed attempts pushing out untrusted vaccine program, data shown 30 - 40% of US citizens did not vaccinated. So the current vaccine program somewhat failed.
- FED intent to have interest rate hike 3 times or may be more to control inflation, the driver for the Inflation was created by the Biden Administration printing excessive amount of money for people.
2022 Market Condition:
INOVIO stock symbol INO
Our #1 pick stock INOVIO, INOVIO can have their first product coming out to the market sooner then later due to high infection of COVID variants.
INO-4800 is a DNA vaccine that targets Covid spike proteins. DNA plasmids are delivered directly to cells in the body through electroporation methods to produce special white blood cells, killer T cells. The phase III solidarity trials test of INO-4800 was approved by six countries: United States, Brazil, the Philippines, Mexico, and Colombia. The efficacy is evaluated after administering twice a month to adults over the age of 18. Interim results are expected in 2022. The vaccine based on recombinant protein platform. It has proven its safety in the human body and easy to store, transport and commission.
- The future vaccine with an injection device (CELLECTRA) which patterned in 2021. Ready for product launch globally.
- World Health Organization assisted carrying out a large golden trails across 7 countries. for final phase of safety and durability test. Superior product efficacy results will be based on the determination of the product launch. Global market orders will follow as proven phase 1 and 2.
- DNA Medicines technology optimized plasmid design to have 18 times more T-cells.
- First 100 millions vaccine dose production capacity is promised by CEO.
- The company is back by many high MDs and Biochemist.
- Once proven to the world powering DNA Medicines works. The sky is limit. Their pipelines are ready to launch to become a big Bio Tech in the sector.
Stock price performance
Stock closing Friday 4.45, after market went up 4.47. Due to high volume calls, writers are in control of the stock price. The more calls purchase the stock. The harder for the stock to go up.
GORKAM Investment Group
Stock and Digital Private Equity
We write periodic articles for our capital investment. Research ideas on wall street and share on gorkam.com and on social media for free. We make great impacts on investment on long term investment not for short term.
Investors should make their own judgement calls based on how much risk they can take, everyone's risk tolerance are very different.